I graduated from the University of Surrey in 2019 with a BSc (Hons) in Biochemistry. My research project focused on the potential for the production of a universal ‘off-the-shelf’ CAR T-cell therapy for the treatment of chronic lymphocytic leukaemia. As part of my undergraduate degree, I also spent an Erasmus year at the Karolinska Institute, Stockholm, where I worked with an animal model of Multiple Sclerosis. I then went on to study an MPhil in Translational Biomedical Research at the University of Cambridge, where I investigated the genetic basis of certain auto-inflammatory diseases. I joined the Chiappini Lab in September 2020 as a PhD student at King’s College London, with an ambition of developing a microfluidics-based platform for cell and gene therapy manufacturing applications, as part of a collaborative effort with MicrofluidX.